These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 1531749

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The binding domain of von Willebrand factor to sulfatides is distinct from those interacting with glycoprotein Ib, heparin, and collagen and resides between amino acid residues Leu 512 and Lys 673.
    Christophe O, Obert B, Meyer D, Girma JP.
    Blood; 1991 Nov 01; 78(9):2310-7. PubMed ID: 1834252
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mapping of distinct von Willebrand factor domains interacting with platelet GPIb and GPIIb/IIIa and with collagen using monoclonal antibodies.
    Girma JP, Kalafatis M, Piétu G, Lavergne JM, Chopek MW, Edgington TS, Meyer D.
    Blood; 1986 May 01; 67(5):1356-66. PubMed ID: 3008890
    [Abstract] [Full Text] [Related]

  • 5. Localization of a collagen-interactive domain of human von Willebrand factor between amino acid residues Gly 911 and Glu 1,365.
    Kalafatis M, Takahashi Y, Girma JP, Meyer D.
    Blood; 1987 Nov 01; 70(5):1577-83. PubMed ID: 2889486
    [Abstract] [Full Text] [Related]

  • 6. A major factor VIII binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand factor.
    Foster PA, Fulcher CA, Marti T, Titani K, Zimmerman TS.
    J Biol Chem; 1987 Jun 25; 262(18):8443-6. PubMed ID: 3110147
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Abnormality of the N-terminal portion of von Willebrand factor in type IIA and IIC von Willebrand disease.
    Takahashi Y, Kalafatis M, Girma JP, Meyer D.
    Thromb Haemost; 1988 Dec 22; 60(3):498-505. PubMed ID: 3266380
    [Abstract] [Full Text] [Related]

  • 14. Substructure of human von Willebrand factor. Proteolysis by V8 and characterization of two functional domains.
    Fretto LJ, Fowler WE, McCaslin DR, Erickson HP, McKee PA.
    J Biol Chem; 1986 Nov 25; 261(33):15679-89. PubMed ID: 3536910
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Requirements of von Willebrand factor to protect factor VIII from inactivation by activated protein C.
    Koppelman SJ, van Hoeij M, Vink T, Lankhof H, Schiphorst ME, Damas C, Vlot AJ, Wise R, Bouma BN, Sixma JJ.
    Blood; 1996 Mar 15; 87(6):2292-300. PubMed ID: 8630390
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Epitope mapping of inhibitory monoclonal antibodies to human von Willebrand factor by using recombinant cDNA libraries.
    Piétu G, Ribba AS, Chérel G, Siguret V, Obert B, Rouault C, Ginsburg D, Meyer D.
    Thromb Haemost; 1994 Jun 15; 71(6):788-92. PubMed ID: 7974349
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.